PL88748B1 - - Google Patents
Download PDFInfo
- Publication number
- PL88748B1 PL88748B1 PL1974169070A PL16907074A PL88748B1 PL 88748 B1 PL88748 B1 PL 88748B1 PL 1974169070 A PL1974169070 A PL 1974169070A PL 16907074 A PL16907074 A PL 16907074A PL 88748 B1 PL88748 B1 PL 88748B1
- Authority
- PL
- Poland
- Prior art keywords
- formula
- substituted
- wzdr
- thallium
- mercury
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Catalysts (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Claims (6)
1. Zastrzezenia patentowe 1. Sposób wytwarzania pochodnych kwasu 7-acy- 50 loaminodezacetoksycefalosporanowego o wzorze 1, w którym R oznacza grupe benzylowa, fenoksy- metylowa, Ill-rzed. butoksylowa, 2-tenylowa, cy- janometylowa, alkilowa o 1—6 atomach wegla, pod¬ stawiona igrupe benzylowa, która w pierscieniu *5 fenylowym moze byc podstawiona grupami hydro¬ ksylowymi, alkoksylowymi, alkilotio i atomami chlorowca, a w grupie metylenowej nizsza grupa alkilowa, grupa aminowa, acyloaminowa, alkoksy- karbonyflowa i grupa o wzorze 3, w którym X 60 oznacza grupe alkilowa o 1—4 atomach wegla, R' oznacza grupe p-nitrofoenzylowa, p-metoksy^ benzylowa, /?,£/?-trójchloroetylowa, dwufenylome- tylowa, 9-fluorenylowa, Ill-rzed. butylowa, try- tylowa, fenacylowa, p-chlorofenacylowa, p-lbromo- w fenacylowa! p-nitrofenacylowa i cyjanometylowa,88748 10 znamienny tym, ze S-tlenki estrów penicyliny o wzorze 2, w którym R i R' maja wyzej podane znaczenie, ogrzewa sie w ciagu 10 minut do 5 go¬ dzin w temperaturze 60—150°C, w obecnosci soli metali ciezkich o wzorze Me (R*—SO$)n przy czym Me oznacza atom miedzi, srebra, zlota, cynku, kad¬ mu, rteci, talu, cyny, olowiu, zelaza, kobaltu lub niklu, zwlaszcza atom miedzi, cyny, srebra, rteci i talu, R" oznacza rodnik alkilowy o 1—4 ato¬ mach wegla ewentualnie podstawiony fluorem lub rodnik fenyIowy lub naftyIowy ewentualnie pod¬ stawiony rodnikami metylowymi lub atomami chlorowca, a n oznacza 1—3 w zaleznosci od war¬ tosciowosci kationu metalu.
2. Sposób wedlug zastrz. 1, znamienny tym, ze reakcje prowadzi sie w temperaturze 80—130°C.
3. Sposób wedlug zastrz. 1, znamienny tym, ze sole metali ciezkich wprowadza sie w ilosci 1—20, zwlaszcza 3—10*/« molowych w przeliczeniu na uzy¬ ty S-tlenek.
4. Sposób wytwarzania pochodnych kwasu 7-acy- loaminodezacetoksycefalosporanowego o wzorze 1, w którym R oznacza podstawiona grupe benzylo¬ wa, która w pierscieniu fenyIowym moze byc pod¬ stawiona grupami hydroksylowymi, alkoksylowy- mi, alkilotio i atomami chlorowca, a w grupie me¬ tylenowej grupa azydowa, a R' oznacza grupe ip-nitrobenzylowa, p-metoksybenzylowa, /?,//,/?-tfój- chloroetylowa, dwufenylometylowa, 9-flucreny- lowa, III-butylewa, trytylowa, fenacylowa, p-chlo- 5 rofenacylowa, p-bromofenacylowa, p-nitrofenacy- lowa i cyjanometylowa, znamienny tym, ze S-tlen¬ ki estrów penicyliny o wzorze 2, w którym R i R' imaja wyzej podane znaczenie, ogrzewa sie w cia¬ gu 10 minut do 5 godzin w temperaturze 60— io i5fr°C, w obecnosci soli metali ciezkich o wzorze Me dzi, srebra, zlota, cynku, kadmu, rteci, talu, cy¬ ny, olowiu, zelaza, kobaltu lub. niklu, zwlaszcza atom miedzi, cyny, srebra, rteci i talu, R" ozna¬ cza rodnik alkilowy o 1—4 atomach wegla ewen¬ tualnie podstawiony fluorem lub rodnik fenylo- wy lub naftylówy ewentualnie podstawiony rodni¬ kami metylowymi lub atomami chlorowca, a n oznacza 1—3 w zaleznosci od wartosciowosci ka¬ tionu metalu.
5. Sposób wedlug zastrz. 2, znamienny tym, ze reakcje prowadzi sie w temperaturze 80—130°C.
6. Sposób wedlug zastrz. 2, znamienny tym, ze sole metali ciezkich wprowadza sie w ilosci 1—20, zwlaszcza 3—10f/» molowych w przeliczeniu na uzyty S-tlenek. 15 20 C00R' WZtfR 1 v-C0-NH- 0 o t r -N C00R' WZCfR 2 -NH-OCH-C00X CH, WZÓR 388748 Oo-^co-^p^^ 0 I 7— ( WZdR 4 C02CH2-^)-N02 o-°-^-c°-n^^CH3_ C02CH2-^M)CH3 WZdR 5 ^CH2-C0-NHT=r NV^CH3 Ol3,, C02-CH2-^_/-0CH3 WZÓR 6 {~^)-0-CH2-C0-NH 0 WZÓR 7 C02-CH2-CN88718 -0-CH-CO-NH |^~NY^CH, C02-CH2-C0-{ "VBr WZÓR 8 -0-CH-CO-NH-| ( 0/-y^CH3 WZdR 9 ^^-CH-CO--NH N ^' ,N3 O CK, C02-CH2-\ ^N02 WZdR 1088748 O t 65 2 J li r^CH, O -H20 COO-CH2-/^h NO. C6H5-0- CH2-C0- NH~! { O M ^J—CH, COO-CKH^^NCL SCHEMAT DN-3, zam. 162.77 Cena 10 zt PL PL
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19732309599 DE2309599A1 (de) | 1973-02-26 | 1973-02-26 | Verfahren zur herstellung von 7-acylamino-desacetoxy-cephalosporansaeurederivaten |
Publications (1)
Publication Number | Publication Date |
---|---|
PL88748B1 true PL88748B1 (pl) | 1976-09-30 |
Family
ID=5873158
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL1974169070A PL88748B1 (pl) | 1973-02-26 | 1974-02-25 |
Country Status (20)
Country | Link |
---|---|
US (1) | US3997533A (pl) |
JP (1) | JPS49117489A (pl) |
AT (1) | AT330350B (pl) |
AU (1) | AU476881B2 (pl) |
BE (1) | BE811521A (pl) |
CA (1) | CA1032156A (pl) |
CH (1) | CH591498A5 (pl) |
DD (1) | DD113549A5 (pl) |
DE (1) | DE2309599A1 (pl) |
EG (1) | EG11155A (pl) |
ES (1) | ES423619A1 (pl) |
FR (1) | FR2219167B1 (pl) |
GB (1) | GB1420573A (pl) |
HU (1) | HU168588B (pl) |
IL (1) | IL44265A (pl) |
LU (1) | LU69477A1 (pl) |
NL (1) | NL7402533A (pl) |
PL (1) | PL88748B1 (pl) |
RO (1) | RO63497A (pl) |
ZA (1) | ZA741210B (pl) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4164586A (en) * | 1974-07-19 | 1979-08-14 | Hoffmann-La Roche Inc. | Therapeutic agent for improving cardiovascular function |
US4096329A (en) * | 1976-03-05 | 1978-06-20 | E. R. Squibb & Sons, Inc. | 7-Cyanoalkylureido 3 heterocylic thio methyl cephalosporins |
US4128723A (en) * | 1977-02-02 | 1978-12-05 | E. R. Squibb & Sons, Inc. | Cyanoalkylureido cephalosporins |
US4096330A (en) * | 1977-04-21 | 1978-06-20 | E. R. Squibb & Sons, Inc. | 7β-[[[(2-Cyanomethyl)amino]-1,2-dioxoethyl]amino]acyl cephalosporins |
US4518773A (en) * | 1978-04-03 | 1985-05-21 | Bristol-Myers Company | "3-Carbamoyloxy cephalosporins" |
US4426520A (en) | 1978-04-03 | 1984-01-17 | Bristol-Myers Company | 3-Carbamoyloxy-cepham-4-carboxylic acid derivatives |
US4310459A (en) * | 1978-04-03 | 1982-01-12 | Bristol-Myers Company | Process for producing carbamoyl substituted penams and carbamoyl substituted cephams from penicillin sulfoxide esters |
US4322347A (en) * | 1978-04-03 | 1982-03-30 | Bristol-Myers Company | 2-Carbamoyloxymethyl-penicillin derivatives |
US4168266A (en) * | 1978-05-30 | 1979-09-18 | E. R. Squibb & Sons, Inc. | 6-[[[(2-Cyanomethyl)amino]-1,2-dioxoethyl]-amino]acyl penicillins |
US4174399A (en) * | 1978-07-10 | 1979-11-13 | Syntex (Usa) Inc. | Treatment of lactic acidosis in ruminants |
US4374982A (en) * | 1979-11-07 | 1983-02-22 | Bristol-Myers Company | Cepham compounds |
CN103058932B (zh) * | 2013-02-01 | 2015-10-07 | 京博农化科技股份有限公司 | N-(2-苯并咪唑基)-氨基甲酸甲酯的合成方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO138629C (no) * | 1969-03-11 | 1978-10-11 | Glaxo Lab Ltd | Fremgangsmaate for fremstilling av 7beta-acylamidometyl-ceph-3-em-4-karboksylsyre-estere. |
US3853861A (en) * | 1969-03-18 | 1974-12-10 | Lilly Co Eli | Cephalexin intermediate |
GB1312233A (en) * | 1969-12-05 | 1973-04-04 | Glaxo Lab Ltd | Cephalosporin compounds |
YU35448B (en) * | 1970-02-18 | 1981-02-28 | Koninkl Gist Spiritus | Process for obtaining 7-substituted amino-deacetoxy cephalosporanic acids |
US3799924A (en) * | 1970-12-18 | 1974-03-26 | Lilly Co Eli | Ester cleavage process |
DE2064107A1 (de) * | 1970-12-28 | 1972-07-06 | Farbwerke Hoechst AG vormals Meister Lucius & Brüning, 6000 Frankfurt | Verfahren zur Herstellung von Cephem-4-carbonsäureestern |
GB1431174A (en) * | 1972-06-30 | 1976-04-07 | Clin Midy | Process for the conversion of a penicillin s-oxide into a corresponding desacetoxycephalosporin |
-
1973
- 1973-02-26 DE DE19732309599 patent/DE2309599A1/de active Pending
-
1974
- 1974-02-14 US US05/442,810 patent/US3997533A/en not_active Expired - Lifetime
- 1974-02-19 RO RO7400077746A patent/RO63497A/ro unknown
- 1974-02-19 CA CA192,962A patent/CA1032156A/en not_active Expired
- 1974-02-20 DD DD176699A patent/DD113549A5/xx unknown
- 1974-02-22 JP JP49020658A patent/JPS49117489A/ja active Pending
- 1974-02-22 AU AU65909/74A patent/AU476881B2/en not_active Expired
- 1974-02-22 LU LU69477A patent/LU69477A1/xx unknown
- 1974-02-22 CH CH255274A patent/CH591498A5/xx not_active IP Right Cessation
- 1974-02-22 IL IL44265A patent/IL44265A/en unknown
- 1974-02-23 EG EG51/74A patent/EG11155A/xx active
- 1974-02-25 ZA ZA00741210A patent/ZA741210B/xx unknown
- 1974-02-25 NL NL7402533A patent/NL7402533A/xx unknown
- 1974-02-25 BE BE141341A patent/BE811521A/xx unknown
- 1974-02-25 GB GB842174A patent/GB1420573A/en not_active Expired
- 1974-02-25 PL PL1974169070A patent/PL88748B1/pl unknown
- 1974-02-25 ES ES423619A patent/ES423619A1/es not_active Expired
- 1974-02-26 AT AT155474A patent/AT330350B/de not_active IP Right Cessation
- 1974-02-26 FR FR7406499A patent/FR2219167B1/fr not_active Expired
- 1974-02-26 HU HUBA3036A patent/HU168588B/hu unknown
Also Published As
Publication number | Publication date |
---|---|
ATA155474A (de) | 1975-09-15 |
CA1032156A (en) | 1978-05-30 |
DD113549A5 (pl) | 1975-06-12 |
BE811521A (fr) | 1974-08-26 |
GB1420573A (en) | 1976-01-07 |
IL44265A0 (en) | 1974-05-16 |
FR2219167A1 (pl) | 1974-09-20 |
AU476881B2 (en) | 1976-10-07 |
NL7402533A (pl) | 1974-08-28 |
ZA741210B (en) | 1975-01-29 |
US3997533A (en) | 1976-12-14 |
EG11155A (en) | 1977-05-31 |
JPS49117489A (pl) | 1974-11-09 |
LU69477A1 (pl) | 1974-09-25 |
USB442810I5 (pl) | 1976-02-24 |
FR2219167B1 (pl) | 1977-09-23 |
ES423619A1 (es) | 1976-05-01 |
CH591498A5 (pl) | 1977-09-30 |
DE2309599A1 (de) | 1974-09-05 |
AT330350B (de) | 1976-06-25 |
IL44265A (en) | 1976-10-31 |
RO63497A (fr) | 1978-10-15 |
AU6590974A (en) | 1975-08-28 |
HU168588B (pl) | 1976-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL88748B1 (pl) | ||
CA1238910A (en) | CARBOXYALKENOIC ACIDS | |
DE3368695D1 (en) | Metal production by electrolysis of a molten electrolyte | |
EP0096990A3 (en) | Metal production by electrolysis of a molten metal electrolyte | |
AR240913A2 (es) | Complejos aminoacido-metalicos utiles como estabilizadores para los polimeros de haluro vinilicos y composiciones estabilizadoras y estabilizadas que los contienen | |
IT1174493B (it) | Processo per il bloccagio di composti dello zolfo, che risultino come prodotti di reazione nella combustione di sostanze combustibili contenenti zolfo, in un impianto di combustione, mediante l'aggiunta di additivi | |
NZ195547A (en) | Manufacture of cephalosporins intermediates | |
PT77878B (de) | Cephalosporinderivate und verfahren zu ihrer herstellung | |
PT77877B (de) | Cephalosporinderivate und verfahren zu ihrer herstellung | |
PT79118B (de) | Cephalosporinderivate und verfahren zur ihrer herstellung | |
JPS5742690A (en) | Thieno 3,2-b pyridinecarboxylic acid derivative | |
EP0206364A3 (en) | Heterocyclic amidinoureas | |
GB1058535A (en) | 7-(-a,-ß-unsaturated acylamino)cephalosporanic acid and derivatives thereof | |
DE3367214D1 (en) | Hexahydrodioxopyrimidines, their production and use | |
ES2019199A6 (es) | Un procedimiento para preparar un derivado de indano. | |
JPS56164184A (en) | Novel piperidine derivative | |
KR830010089A (ko) | 1,4-티아잔-카르복시산 유도체의 제조방법 | |
EP0043194A3 (en) | Bicyclo-octatriene derivatives, pharmaceutical compositions containing them and processes and intermediates for their production | |
ATE135693T1 (de) | Halogeno-4-methylpyrazole und verfahren zu ihrer herstellung | |
EP0202195A3 (de) | Verfahren zur Herstellung von Pyridinyloxy-nitrobenzol-Derivaten | |
ES8107233A1 (es) | Procedimiento para la obtencion de nuevas cefalosporinas | |
EP0175233A3 (de) | Substituierte 1,1-Bis-azolyl-butan-2-one und -ole | |
JPS5798490A (en) | Method of controlling quantity of charge by crane with bucket | |
PL66763B1 (pl) | ||
ATE16386T1 (de) | Triazolverbindungen, verfahren zu ihrer herstellung und diese enthaltende fungizide. |